A key gap in buprenorphine access: 5 things to know

Becker's Healthcare April 17, 2025
Rylee Wilson

Fewer than one in five Medicare enrollees with opioid use disorder received any medication treatment, according to a report from HHS’ Office of Inspector General.

The report, published April 15, examined access to buprenorphine for Medicare beneficiaries in 2023. That year, the number of providers prescribing buprenorphine to Medicare Part D enrollees increased by 32%, but the overall share of enrollees receiving treatment remained low.

Here are five things to know:

1. In 2023, around 1.2 million Medicare beneficiaries had a diagnosis of opioid use...

Today's Sponsors

Today's Sponsor